Salmonella vaccination programs using killed bacterins in breeders and live auxotrophic-strain vaccines early in the life of their progeny have gained popularity in today's poultry industry. In this study we evaluated the intestinal humoral immune response to a live auxotrophic vaccine used on hatchlings with and without maternal antibody and related this response to challenge with a blend of two antibiotic-resistant Salmonella marker strains. Forty wk-old ISA Brown (Institute de Selection Animale, France) breeders from ® a Salmonella-free flock were vaccinated twice at a three wk interval with commercially-prepared autogenous trivalent bacterin, serogroups B, C and D1 (Lohmann Animal Health International, Gainesville, GA), or a serovar Enteritidis bacterin (Fort Dodge Animal Health Inc, Overland Park, KS). Half of the progeny from these treatments (hatched from eggs laid 3 wks after second bacterin dose) were given a live Salmonella serovar Typhimurium (LiveST) mutant vaccine (Fort Dodge Animal Health Inc, Overland Park, KS), by coarse spray on arrival in the brooding premises. On days 3, 13 and 34, intestinal immunoglobulins (Ig) A and G were sampled and measured on enzyme-linked immunosorbent assay plates coated with Salmonella serovars Enteritidis (SELPS) or Typhimurium (STLPS) Lipopolysaccharide. On the same days, a second group of birds was challenged with a blend of antibiotic-resistant serovars Enteritidis and Typhimurium strains. Cecal and composite liver-heart-spleen samples obtained 7 days post-challenge were cultured and colonies enumerated. Maternal IgG observed up to 13 days had no effect on subsequent LiveST-stimulated antibody production. No protective effect of maternal antibody was demonstrated, except when combined with LiveST given to the progeny. Killed vaccines delivered to the breeders combined with a live vaccine delivered to the progeny resulted in reduced invasiveness after challenge, as shown by a reduction in liver-heart-spleen Salmonella counts. One dose of LiveST enhanced intestinal IgG [Optical Densities (OD) >0.576] up to 34 days when measured on STLPS, but only to 13 days when measured on SELPS, with titers decreasing with age. Increased IgA was observed only at 13 days. Three and 13 but not 34 days bacterial counts were decreased by the live ST vaccine treatment, for both cecal (1.05 and 1.09 log ) and liver-heart-spleen (0.32 10 and 0.06 log ) samples, indicating that a second dose might be necessary for prolonged protection. The 10 protective effect of the live vaccine, but not of maternal IgG, leads us to hypothesize that protection might be due to stimulation of cell-mediated intestinal immunity and/or a competitive exclusion effect of the LiveST vaccine. Reduction but not elimination of Salmonella colonization by vaccination highlights the importance of vaccines as complementary tools and not substitutes of integral biosecurity programs to control Salmonella in poultry.
Introduction
Although the cell-mediated and humoral intestinal immune responses are recognized as the primary mechanisms in defense against enteric bacterial pathogens, the intestinal immunoglobulin dynamics of progeny vaccinated with live auxotrophs shortly after hatch and its correlation to actual resistance t o challenge in progeny has not been extensively studied. Vaccination of breeder flocks with autogenous Salmonella vaccines, as well as, vaccination of newlyhatched chicks with live vaccines has gained popularity in the poultry industry. However, there exists potential interference of maternal immunoglobulin in neutralizing live vaccines given early in life. Early studies with turkey poults originating from breeders with a history of a Salmonella serovar Typhimurium field outbreak early in life and vaccinated multiple (4 to 6) times with an autogenous aluminum hydroxide-adjuvanted bacterin showed decreased overall poult mortality when challenged after hatch, compared with hatchlings from unvaccinated dams (McCapes et al., 1967) . Turkey breeders vaccinated twice with a Salmonella serovar Hadar bacterin at 41 consisted of a monovalent serovar Enteritidis bacterin and 45 wks and hatched from eggs laid at 51 wks, (SEBAC), POULVAC-SE (Fort Dodge Animal Health Inc., showed a decrease in the number of positive serovar Overland Park, KS), or a commercially-prepared Hadar isolates compared to turkey poults derived from (Lohmann Animal Health International, Gainesville, GA) non-vaccinated dams up to 39 days (Thain et al., 1984) .
autogenous trivalent bacterin (TRIBAC) comprising A reduction in Salmonella colonization of progeny from serovars Heidelberg (serogroup B) Kentucky (serogroup breeders vaccinated at 16 and 18 wks with a live )cya C ) and Berta (serogroup D ). Breeders were vaccinated )crp vaccine strain has been previously reported at 40 and 43 wks and progeny obtained from eggs laid (Hassan and Curtiss, 1996) . The authors also observed at 46 wks. an interference of maternal antibody on early vaccination, Eggs were manually collected three to four times per day since day-of-hatch delivery of a live serovar Typhimurium from outside the compartments, with nests placed on )cya )crp vaccine strain to progeny with maternal the perimeter of each compartment. Eggs were antibody would clear the vaccine strain by two wks, disinfected immediately after collection by submersion compared to a persistence of the vaccine strain for at in a 0.5% solution of warm (37-45°C x 0.5-2min) Virkonleast 21 day in Specific Pathogen Free birds. In their S (DuPont Animal Health Solutions, Wilmington, DE) study, maternally-derived immunity reduced efficacy of a disinfectant. Eggs were stored for 3-4 days at 14°C until 1 and 3 wk, but not a 2 and 4 wk vaccination program.
incubation. The eggs were incubated in a single stage The present study was set to evaluate the effectiveness NSS-10 (Natureform Hatchery Systems Inc, Jacksonville, of early vaccination with a live Salmonella vaccine and in FL) incubator and hatched in separate trays, in an H-152 the presence of maternal antibody, in protecting (Natureform Hatchery Systems Inc, Jacksonville, FL) hatchlings against Salmonella challenge at days 3, 13
hatcher along with eggs from the same breeder flock and 34. Intestinal humoral (IgA and IgG) immune only. Samples of dead-in-shell embryos and chick box response and Salmonella counts seven days post-liners were also cultured for Salmonella. Chicks were challenge were the parameters evaluated. vaccinated against
Marek's disease (strains
Materials and Methods
Breeders, vaccination and incubation: Forty wk-old ISA Brown® breeders (Institute de Selection Animale, France) in a small commercial operation were used as the parent stock. Breeders were housed in a 13.5
x 34 m open house with six 6.5 x 9.5 m compartments, three on each wing with a central corridor and transverse corridors separating each compartment. Each compartment housed approximately 380 female breeders. Litter material consisted of eucalyptus shavings and equipment consisted of manual bell feeders, automatic bell drinkers and metal nests with eucalyptus shavings as nest material. Nest shavings were changed on a bi-weekly basis, with 15g o f paraformaldehyde added to each nest weekly. As part of the farm's established monitoring programs, routine bi-manual tube feeder between 7 and 14 days. Rooms with monthly environmental sampling for Salmonella during grow-out and production were carried out using drag swab, feed, litter and water samples. A 1% sample of the b reeders were plate-agglutination tested with a polyvalent Salmonella antigen (Intervet International BV, Boxmeer, Holland) at start of production and 0.5-1% again after peak production. Any suspect birds were separated; sacrificed; and fecal and/or cecal samples taken which were cultured for Salmonella. Samples were pre-enriched in tetrathionate-brilliant green broth for 24hrs at 40°C before culturing on brilliant green sulpha agar. Two of the six compartments were randomly chosen for vaccination treatments and a third chosen as a nonvaccinated control. Breeder vaccine treatments 2 1 FC126/SB1/CVI988, Fort Dodge Animal Health Inc, Overland Park, KS) at hatch.
Chick treatments:
On arrival to the farm, 396 chicks were randomized into 3 x 2 treatments (Breeder Bacterin x Live auxotroph vaccine), each treatment wingbanded with different colored bands, with a total of 33 chicks per treatment. While in the chick boxes, treatments receiving POULVAC-ST (Fort Dodge Animal Health Inc, Overland Park, KS) , a live Aro-A auxotroph deletion mutant ® serovar Typhimurium strain (LiveST), were coarse-spray vaccinated and placed in the same room as treatments not receiving the LiveST, but in a different brooding pen. Each brooding pen was equipped with an infrared gas heater, two manual brooding feed pans and waterers, gradually replaced by one automatic bell drinker and brooding pens were previously disinfected b y sublimation of 10 g of paraformaldehyde per m of room 3 volume 48 hrs prior to chick placement and with eucalyptus shavings and brooding equipment in place.
Intestinal immunoglobulin (Ig) sampling: On days 3, 13 and 34, 10 chicks per treatment were sampled for intestinal Ig. Chicks were removed from feed 16 hrs prior to sampling, euthanized and the small intestine excised at the ventriculo-duodenal and ileo-cecal junctions. Five ml of a lavage solution, consisting of 1M Tris/glycerine buffer and 0.25% Tween 20, as used by Holt et al. (1999) was flushed by inserting a feeding needle (Oxoid Inc, Ogdensburg, NY) through the ileal end and collecting flushed material through the duodenal end into 15 mL centrifuge tubes. Samples were kept on ice until kept in ice until processed (less than 2 h). Samples centrifuged at 2,500g for 10 min. The supernatant was frozen at -8°C until the enzyme-linked immunosorbent assay procedure was performed.
Elisa assays: The ELISA protocol was completed on each sample as previously described (Holt and Porter, 1993) . Briefly, the assays were conducted using 96-well Immulon plates (Dynex Technologies, Inc., Chantilly, ® VA) coated with Lipopolysaccharide from serovars Typhimurium (STLPS) or Enteritidis (SELPS) (Sigma Chemical Co., Saint Louis, MO), at a concentration of 10µL/ml, incubated overnight and blocked with a solution consisting of 1% bovine serum albumin, 1% phosphate buffered saline and 0.5ml/L Tween 2 0 (Sigma, Saint Louis MO). The blocking step solution was added to the plates for one hour. All plates were washed between steps twice with a 1% phosphate buffered saline p lus 0.5ml/L Tween 20, for 2 to 3 minutes. Intestinal lavage samples were diluted 1:2 and added to the microplates together with controls and incubated for 90 minutes. Primary antibodies were mouse antichicken IgA or mouse anti-chicken IgG (Southern Biotech, Birmingham, AL) and diluted 1:1000. Primary antibodies were incubated for one hour. Secondary antibody was a goat anti-mouse heavy and light chainspecific IgG (Calbiochem, La Jolla, CA), used at a 1:2000 dilution and incubated for one hour. Para-nitrophenyl phosphate chromogen (Sigma, Saint Louis, MO) at a 1mg/mL concentration diluted in diethanolamine (Sigma, Saint Louis, MO) was added, incubated for 20-30 minutes under dark conditions and plates read at 405nm.
Bacterial challenge:
On the same days (3, 13 and 34), 10 chicks per treatment were challenged with a blend of 10 -10 CFU/ml of a nalidixic acid resistant Serovar 7 8
Enteritidis and a Rifampicin resistant serovar Typhimurium strains. Strains were grown 24hrs earlier on brilliant green sulpha agar with 200 ppm o f corresponding antibiotic (rifampicin or nalidixic acid) and cells suspended in 0.85% saline. Cell suspensions were adjusted to 0.120 OD at 540nm and equal aliquots mixed prior to gavaging. The gavaging mix was plated and colonies counted to confirm that the mixed colony concentration was within the 10 -10 cfu/ml range. Each 8 9
chick was gavaged with 0.1ml of challenge mixture. Challenged chicks of all treatments were placed together in one brooding pen, in a separate room from non-challenged chicks. Seven days after challenge, six chicks per treatment were euthanized and sampled for bacterial enumeration. The left liver lobule, heart and spleen were pooled, weighed and placed in a stomacher filter bag (Fischer Scientific International Inc, Hampton, NH). Both ceca were removed and placed in a second stomacher bag with filter. All samples were were weighed and peptone broth corresponding to 3 times sample weight added. Samples were stomached thoroughly and plated for enumeration as reported earlier (Bailey et al., 1988) 
Results
Intestinal IgA profiles showed no measurable maternally-derived IgA, as revealed by similar OD of all treatments by day 3 (Fig. 1) . Live vaccination elicited a small increase in intestinal IgA by day 13; the largest increase observed was on STLPS. The increased IgA was temporary (OD>0.65) and not present by day 34. In contrast, treatment IgG profiles shown (Fig. 2) for chicks from vaccinated breeders were higher than for chicks from non-vaccinated breeders at day 3 (OD>0.75). IgG titers decreased by day 13 and were no different from controls by day 34. Live vaccination increased IgG by day 13 (OD >0.75), but titers showed a declining trend by day 34. and lasted longer when measured on STLPS, as seen statistically significant (p<0.05) by increased titers for days 13 (mean OD = 0.934) and 34 (mean OD = 0.576). Maternally-derived IgG was interaction for IgG measured on SELPS between LiveST higher for the TRIBAC treatment at day 3 when and SEBAC shows a smaller rate of titer increase for measured on SELPS and titers were higher from non-SEBAC chicks that received LiveST than for non-SEBAC vaccinated controls throughout all sampling days when chicks that received LiveST for day 13 samples. Analysis measured on STLPS. Although higher IgG was observed of this interaction shows that non-SEBAC chicks by day 34 for TRIBAC chicks, there was a consistent receiving LiveST increased mean OD from 0.408 t o decrease in titers through time, as would be expected, 0.624, whereas SEBAC chicks receiving LiveST showed with treatment means between TRIBAC and No-TRIBAC only a slight increase of mean OD, from 0.590 to 0.621. effects being very similar by day 34 (0.418 vs. 0.507 OD These data show that LiveST will result in similar end for No-TRIBAC and TRIBAC groups respectively). The titers (OD of 0.621 and 0.624) regardless of the same decrease in titers with time was observed with IgG presence or not of maternally-derived antibody due to measured on SELPS, but significant differences were SEBAC treatment. Although an interaction for 34 day IgG observed only for days 3 and 13. A significative on STLPS was detected, breakdown of data show OD superscripts within each sampling day are Total Salmonella counts showed no differences between treatments for cecal samples, but some differences were observed for liver-heart-spleen samples (Fig. 3) . No Salmonella was recovered from liver-heart-spleen cultures from all treatments including breeder killed bacterin and live progeny vaccination, except for day 13 LiveST + SEBAC treatment. These differences were significant for days 3 and 34, but not for day 13. Although the LiveST treatment when contrasted to the other treatments did not show a decrease in liverheart-spleen Salmonella counts, a factorial analysis of main effects (Table 2) reveals differences for LiveST for days 3 and 13, but not for day 34. Cecal sample data showed Salmonella count reductions of 1.05 and 1.09 log and liver-heart-spleen sample data showed 10 reductions of 0.319 and 0.125 log for days 3 and 13 10 samples.
Discussion
The different IgG and IgA profiles at day 3 in chicks from vaccinated breeders show IgG is the most prevalent maternally-derived immunoglobulin type. Although we did not measure IgG and IgA levels in the breeders after vaccination, it appears that two doses of killed antigen delivered to the breeders induced IgG but not IgA passive immunity to the progeny. Maternal IgG i s deposited in the egg yolk and IgA is deposited in the amniotic fluid, which is swallowed by the embryo prior to hatching (Rose et al., 1974) . Passive yolk-derived IgG is parenterally transferred to the embryo through the vitelline vessels, or enters the intestinal lumen via the omphaloenteric duct and can be detected as early as 3 days prior to hatch (Kimijama et al., 1990; Magyar et al., 1997) . Maternally derived IgG in serum is reported to be highest immediately after hatch and decreases after 2 to 5 wks (Kowalczyyk et al., 1985) . In our study, intestinal IgG followed a similar trend. We were unable to clearly demonstrate interference of maternally-derived immunoglobulins on the LiveST vaccination treatment's ability to elicit increased IgG and IgA titers in the offspring of the vaccinated breeders. However, treatments combining breeder vaccination and progeny LiveST were the most effective in eliciting higher IgG titers for days 13 and 34 and IgA titers for day 13. This effect is more evident when reviewing the ELISA data using STLPS antigen. Higher titers on STLPS would be expected when the birds were vaccinated with a serogroup B (LiveST). LiveST is a serovar Typhimurium strain and serovar Heidelberg, contained in the TRIBAC bacterin, is a group B serovar, therefore they share common somatic antigens 4, 12 and possibly 5 (Anonymous, 1998) . We observed marginally lower IgG titers for the SEBAC treatment when measured o n STLPS and marginally higher titers when measured on SELPS. In general, ELISAS using LPS as capture antigen tend to be more sensitive as somatic antigen homology with the challenge/vaccine strain eliciting the immune response increases. IgA priming by the liveST was shorter lived than IgG. Previous research has shown serum IgA and IgG titers after six wk-old prime-infection with an invasive serovar Typhimurium strain to persist up to 10 wks post challenge (Beal et al., 2004) . However, immunoglobulin responses on younger birds elicited by LiveST appear to be shorter lasting. This may be explained in part by the lack of invasive nature of the auxotroph mutant, as well responses are important components of immunity as, by the hypo-responsiveness of young birds to early infection (Holt et al., 1999) . Although LiveST and TRIBAC yielded higher IgG responses throughout 34 days (Table  1) , IgG titers consistently decreased after day 13, approaching control values by day 34. A second dose of LiveST is probably necessary if longer-lasting immunoglobulin titers are desired, such as for birds with a longer lifespan than commercial broilers (i.e. breeders and layers). The lack of treatment differences for total Salmonella cecal counts despite differences in immunoglobulin profiles ( Fig. 1 and 2) show that increased intestinal IgG and IgA were not sufficient to effectively reduce Salmonella incidence. It is interesting to note, however, that combining maternal immunity with LiveST vaccination diminished invasiveness of challenge strains at all sampling events, except for day 1 3 SEBacxLiveST treated birds (Fig. 3b ). Innate and cellmediated immunity as well as adequate humoral against bacterial pathogens. Ontogenic studies of the gut-associated lymphoid tissue have shown the presence of IgG and IgA B cells as early as 5 days posthatch and IgA and IgG plasma cells by 14 days posthatch in the intestinal lamina propia (Jeurissen et al., 1989) . However, a recent study using chicken Interferon ( mRNA as a marker of T-cell effector functionality showed reduced Interferon ( expression of intestinal T cells, leading the authors to conclude that gut resident T cells are functionally immature during the first 2 weeks of life (Bar-Shira et al., 2003) . Similarly, suboptimal functional activity of the heterophil in young chicks as measured by decreased phagocytic indices on 1 and 4 day-old chicks compared to 7 day-old chicks show that innate immunity also undergoes maturation with time (Wells et al., 1998) . The beneficial effect of LiveST in young chicks may be explained not only by an increase in intestinal immunoglobulins, but by colonization and hence Hassan, J.H. and R. Curtiss III, 1996 . Effect o f competitive exclusion effect from the vaccine strain. The vaccination of hens with an avirulent strain o f potential competitive exclusion effect of vaccine strains Salmonella typhimurium on immunity of progeny against Salmonella challenge has been previously challenged with wild-type Salmonella strains. Inf. hypothesized (Berchieri and Barrow, 1990) . Studies Immun., 64: 938-944. combining day-of-hatch vaccine or homologous strain Holt, P.S. and R.E. Porter Jr, 1993. Effect of induced delivery followed shortly (as early as 2 days post molting on the recurrence of a previous Salmonella vaccination) by challenge show a decrease i n enteritids infection. Poult. Sci., 72: 2069-2078. colonization of birds previously vaccinated/colonized Holt, P.S., R.K. Gast, R.E. Porter Jr. and H.D. Stone, (Methner et al., 1997) . The short time lapse between 1999. Hyporesponsiveness of the systemic and vaccination and challenge probably is not enough for mucosal humoral immune systems in chickens an immune response, but a decrease in colonization infected with Salmonella enterica serovar enteritidis apparently points towards an initial competitive-at one day of age. Poult. Sci., 78: in the chicken oviduct. Jap. J. Vet. Sci., 52: 299-305. However, this work shows that by no means may Kowalczyyk, K., K.J. Doiss, J. Halpern and T.F. Roth, vaccination programs be a substitute for implementation 1985. Quantitation of maternal-fetal IgG transport in of adequate biosecurity programs throughout breeding, the chicken. Immunol., 54: 755-762. production and processing.
Magyar, A., A. Tóth, M.K. Gumati and I. Oláh, 1997. The
